Loading organizations...
Wedo Venture Partners is a venture capital firm investing in global biotech and medtech innovation. The firm bridges science, culture, and capital between Eastern and Western markets, fostering new leaders in human health. It connects Asia's talent, clinical resources, and supply networks with global innovation, transforming scientific breakthroughs into scalable healthcare enterprises.
Ms. Summer Qu, an experienced entrepreneurial investor, founded the firm in 2016. Her prior role as Executive Director at Northern Light Venture Capital involved leading key early-stage technology investments. Ms. Qu's founding insight recognized that global innovation is often hindered by market and cultural divides, prompting a platform to empower these scientific and entrepreneurial efforts.
Wedo Venture Partners supports early-stage biotech and medtech companies across diverse therapeutic areas and platforms. The firm’s vision is to unlock human health by translating global potential into meaningful progress. It guides portfolio companies towards widespread impact through successful IPOs, strategic acquisitions, and robust partnerships.
Wedo Venture Management has 1 tracked investment across 1 company. The latest tracked deal is $27.0M Series C in Drug Farm in May 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 16, 2023 | Drug Farm | $27.0M Series C | YD Capital | Betta Capital, Haoyue Capital, Jiashan County State Owned Assets Investment |